Antibiotic News and Research

RSS
MEDIHONEY dressings effective in treating chronic wounds in children

MEDIHONEY dressings effective in treating chronic wounds in children

UDH to participate in Abbott's new PLEX-ID BPEP

UDH to participate in Abbott's new PLEX-ID BPEP

New study may help devise better treatment strategies for cancer and heart disease

New study may help devise better treatment strategies for cancer and heart disease

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

Kenta Biotech presents positive Phase IIa results of panobacumab

Kenta Biotech presents positive Phase IIa results of panobacumab

Use of silver dressing in burn cases questioned

Use of silver dressing in burn cases questioned

Study: New anti-cancer agents halt cancer metastasis

Study: New anti-cancer agents halt cancer metastasis

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

Strains of Salmonella beginning to emerge in HIV-infected people in Africa

Strains of Salmonella beginning to emerge in HIV-infected people in Africa

Link between IL-8, MIF gene polymorphisms and progression of atrophic gastritis and intestinal metaplasia

Link between IL-8, MIF gene polymorphisms and progression of atrophic gastritis and intestinal metaplasia

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Meijer adds Metformin Immediate Release to free medication program

Meijer adds Metformin Immediate Release to free medication program

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Scientists identify specific mechanism that triggers resistance to vancomycin

Scientists identify specific mechanism that triggers resistance to vancomycin

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Effective compound against antibiotic-resistant biofilms

Effective compound against antibiotic-resistant biofilms

Triclosan antibacterial found in soap in the spotlight

Triclosan antibacterial found in soap in the spotlight

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.